Irinotecan Hydrochloride Liposome Injection (Ⅱ) Combined with Fluorouracil, Folinic Acid, Vermofenib and Cetuximab in First-line Treatment of BRAFV600E Mutated Advanced Colorectal Cancer
Clinical trial NCT06603376 · RECRUITING
Trial details
- NCT number
- NCT06603376
- Sponsor
- Shanghai Changzheng Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2026-08-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.